The U.S. Food and Drug Administration (FDA) has seen fit to award Fast Track status to Ohr Pharmaceutical’s Squalamine Eye Drops, according to a press release detailing the situation. The press release noted that the biotechnology company’s promising drug got the FDA’s nod on account of its potential as a medication for those diagnosed with […]